RECORDATI: SUMMARY REPORT OF THE VOTES - ORDINARY GENERAL MEETING OF THE SHAREHOLDERS 22.04.2024

NEWS RELEASE

RECORDATI: SUMMARY REPORT OF THE VOTES - ORDINARY GENERAL MEETING OF THE SHAREHOLDERS 22.04.2024

Milan, 24th April 2024 - Please be informed that the summary report of the voting results related to the resolutions approved by the Ordinary General Meeting of the Shareholders on 22nd April 2024, pursuant to article 125-quater of the Legislative Decree 58/98, is available to the public on the Company's website (www.recordati.it, in the area "Investors", section "Shareholder Information") and on the "1info" storage mechanism (www.1info.it).

Recordati (Reuters RECI.MI, Bloomberg REC IM) is an international pharmaceutical group listed on the Italian Stock Exchange (ISIN IT 0003828271) uniquely structured to bring treatment across specialty and primary care, consumer healthcare, and rare diseases. We believe that health, and the opportunity to live life to the fullest, is a right, not a privilege. We want to support people in unlocking the full potential of their lives. We have fully integrated operations across research & development, chemical and finished product manufacturing through to commercialisation and licensing. Established in 1926, Recordati operates in approximately 150 countries across EMEA, Americas and APAC regions. At the end of 2023, Recordati employed over 4,450 people and consolidated revenue of € 2,082.3 million.

For more information, please visit www.recordati.com

Investor Relations	Investor Relations	Media Relations Brunswick:
Eugenia Litz	Lucia Abbatantuoni	Barbara Scalchi / Andrea Mormandi
[phone]	[phone]	[phone]
[e-mail]	[e-mail]	[e-mail]

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.

Registered office VIA M. CIVITALI, 1 20148 MILAN, ITALY TEL. [phone] FAX [phone]

SHARE CAPITAL € 26,140,644.50 fully paid up

BUSINESS REGISTER OF MILAN, MONZA, BRIANZA and LODI 00748210150

TAX CODE/VAT NO. 00748210150

Company subject to management and coordination by Rossini Luxembourg S.àr.l